All of the following are true about metformin EXCEPT:
**Core Concept**
Metformin is a biguanide class of oral antidiabetic medication that works by decreasing hepatic glucose production and increasing insulin sensitivity.
**Why the Correct Answer is Right**
Metformin acts by inhibiting the mitochondrial respiratory chain complex I, which leads to a decrease in ATP production and a subsequent increase in AMP levels. This increase in AMP activates AMP-activated protein kinase (AMPK), which in turn phosphorylates and inhibits acetyl-CoA carboxylase (ACC), a key enzyme in fatty acid synthesis. This results in a decrease in hepatic glucose production.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because metformin is primarily used to treat type 2 diabetes and is not a first-line treatment for type 1 diabetes.
**Option B:** Incorrect because metformin is not a sulfonylurea and does not stimulate insulin secretion.
**Option C:** Incorrect because metformin does not have a significant effect on pancreatic beta-cell function and does not cause hypoglycemia as a result of increased insulin secretion.
**Clinical Pearl / High-Yield Fact**
Metformin is the first-line treatment for type 2 diabetes due to its efficacy in reducing hepatic glucose production and its safety profile.
**Correct Answer: A.**